OncoLink Cancer Treatment and Resources

Life Expectancy Gains from Cancer Prevention Strategies for Women with Breast Cancer and BRCA1 or BRCA2 Mutations

Deborah Schrag, Karen M. Kuntz, Judy E. Garber, et al.
Abramson Cancer Center of the University of Pennsylvania
Last Modified: November 1, 2001

Reviewers: Li Liu, MD
Source: JAMA, volume 283, No. 5: 617-624, (February) 2000.

Précis: Theoretical benefit of various cancer prevention strategies for breast cancer patients with BRCA mutations

Introduction

Women who carry BRCA1 and BRCA2 mutations have a greatly increased risk of breast and ovarian cancers when compared with the general population. The optimal clinical management of women who have had breast cancer with BRCA mutations has not been established. Dr. Deborah Schrag and her colleagues from Memorial Sloan-Kettering Cancer Center report here in the theoretical benefit of various strategies in breast cancer patients with known BRCA1 or BRCA2 mutations.

Method

A hypothetical cohort of breast cancer patients with BRCA1 or BRCA2 mutations were included. They used a decision analysis model to examine the effects of seven prevention strategies on life expectancy and the risk of second cancers: 5 years of tamoxifen therapy, bilateral prophylactic oophorectomy, prophylactic contralateral mastectomy and combinations of these interventions.

Results

A 30 year-old breast cancer patient with BRCA mutations could gain
  • 0.4 to 1.3 years of life from tamoxifen therapy.
  • 0.2 to 1.8 years of life from prophylactic oophorectomy therapy.
  • 0.6 to 2.1 years of life from contralateral mastectomy therapy.
  • Women with higher penetrance of BRCA mutations appeared to benefit more in terms of the actual gains in life expectancy.

Discussion

Aggressive secondary cancer prevention measures, particularly prophylactic contralateral mastectomy, can add up to 2 years to the life expectancy of young breast cancer patients who test positive for BRCA1 or BRCA2 mutations. Women should discuss strategies of how they prefer to prevent secondary cancer with their physicians. It is important to understand that each strategy has risks and benefits.

OncoLink I wish u knew...

Donna Lee shares how it feels to have cancer and what others can do to help. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS